INVESTOR DEADLINE: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit...

Fluence Energy, Inc. (FLNC) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Kessler Topaz Meltzer & Check,...

Bronstein, Gewirtz & Grossman LLC Urges Endava plc Investors to Act: Class Action Filed Alleging Investor Harm

Prime Minister Carney to host Canada-European Union Summit in Montréal to advance an ambitious new Canada-EU partnership

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Millrose Properties, Inc. Investors with Substantial Losses May Seek...

INVESTOR DEADLINE: Gildan Activewear Inc. Investors with Substantial Losses May Seek to Lead the Gildan Activewear Class Action Lawsuit...

Compass, Inc. (COMP) Class Action Lawsuit: Investors Face December 8, 2026, Deadline - Kessler Topaz Meltzer & Check, LLP

Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform

Duolingo, Inc. (DUOL) Class Action Lawsuit: Investors Face December 7, 2026, Deadline - Kessler Topaz Meltzer & Check, LLP

Bronstein, Gewirtz & Grossman LLC Urges York Space Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against D-Wave Quantum Inc. (NASDAQ: QBTS) — Investors Who...

J.B. Hunt Investor News: If You Have Suffered Losses in J.B. Hunt Transport Services, Inc., You Are Encouraged to Contact The Rosen Law Firm...

Beneficient Investor News: If You Have Suffered Losses in Beneficient, You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Crypto News: Remittix Announces 300 Million RTX Burn at Launch as JPMorgan Brings Two Tokenized Funds to Solana, Building the Case for a ...

Unifor vows to defend workers' rights under the next B.C. government

Azenta, Inc. Investor News: If You Have Suffered Losses in Azenta, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of...

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Honeywell Aerospace Inc. Investors to Secure Counsel Before Important Deadline in Securities...

LexisNexis Coplogic Solutions Introduces Field Clarity for LexisNexis® Desk Officer Reporting System (DORS) at IACP 2026

30 Years of DMV Title Closings, Now With Digital Tools